201 related articles for article (PubMed ID: 23296746)
1. Buffer capacity of biologics--from buffer salts to buffering by antibodies.
Karow AR; Bahrenburg S; Garidel P
Biotechnol Prog; 2013; 29(2):480-92. PubMed ID: 23296746
[TBL] [Abstract][Full Text] [Related]
2. Buffer-free therapeutic antibody preparations provide a viable alternative to conventionally buffered solutions: from protein buffer capacity prediction to bioprocess applications.
Bahrenburg S; Karow AR; Garidel P
Biotechnol J; 2015 Apr; 10(4):610-22. PubMed ID: 25641961
[TBL] [Abstract][Full Text] [Related]
3. Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation.
Kolhe P; Amend E; Singh SK
Biotechnol Prog; 2010; 26(3):727-33. PubMed ID: 20039442
[TBL] [Abstract][Full Text] [Related]
4. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
Garidel P; Pevestorf B; Bahrenburg S
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
[TBL] [Abstract][Full Text] [Related]
5. Self-buffering antibody formulations.
Gokarn YR; Kras E; Nodgaard C; Dharmavaram V; Fesinmeyer RM; Hultgen H; Brych S; Remmele RL; Brems DN; Hershenson S
J Pharm Sci; 2008 Aug; 97(8):3051-66. PubMed ID: 18023013
[TBL] [Abstract][Full Text] [Related]
6. Influence of pH, buffer species, and storage temperature on physicochemical stability of a humanized monoclonal antibody LA298.
Zheng JY; Janis LJ
Int J Pharm; 2006 Feb; 308(1-2):46-51. PubMed ID: 16316730
[TBL] [Abstract][Full Text] [Related]
7. Improving pH gradient cation-exchange chromatography of monoclonal antibodies by controlling ionic strength.
Zhang L; Patapoff T; Farnan D; Zhang B
J Chromatogr A; 2013 Jan; 1272():56-64. PubMed ID: 23253120
[TBL] [Abstract][Full Text] [Related]
8. Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1.
Barnett GV; Razinkov VI; Kerwin BA; Hillsley A; Roberts CJ
J Pharm Sci; 2016 Mar; 105(3):1066-73. PubMed ID: 26886346
[TBL] [Abstract][Full Text] [Related]
9. Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution.
Jang SW; Woo BH; Lee JT; Moon SC; Lee KC; DeLuca PP
Pharm Dev Technol; 1997 Nov; 2(4):409-14. PubMed ID: 9552470
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the myotoxicity of pharmaceutical buffers using an in vitro muscle model: effect of pH, capacity, tonicity, and buffer type.
Napaporn J; Thomas M; Svetic KA; Shahrokh Z; Brazeau GA
Pharm Dev Technol; 2000; 5(1):123-30. PubMed ID: 10669926
[TBL] [Abstract][Full Text] [Related]
11. Solution pH that minimizes self-association of three monoclonal antibodies is strongly dependent on ionic strength.
Sule SV; Cheung JK; Antochshuk V; Bhalla AS; Narasimhan C; Blaisdell S; Shameem M; Tessier PM
Mol Pharm; 2012 Apr; 9(4):744-51. PubMed ID: 22221144
[TBL] [Abstract][Full Text] [Related]
12. Specific ion and buffer effects on protein-protein interactions of a monoclonal antibody.
Roberts D; Keeling R; Tracka M; van der Walle CF; Uddin S; Warwicker J; Curtis R
Mol Pharm; 2015 Jan; 12(1):179-93. PubMed ID: 25389571
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody heterogeneity analysis and deamidation monitoring with high-performance cation-exchange chromatofocusing using simple, two component buffer systems.
Kang X; Kutzko JP; Hayes ML; Frey DD
J Chromatogr A; 2013 Mar; 1283():89-97. PubMed ID: 23428023
[TBL] [Abstract][Full Text] [Related]
14. Effect of protein and solution properties on the Donnan effect during the ultrafiltration of proteins.
Bolton GR; Boesch AW; Basha J; Lacasse DP; Kelley BD; Acharya H
Biotechnol Prog; 2011; 27(1):140-52. PubMed ID: 21312362
[TBL] [Abstract][Full Text] [Related]
15. Influence of calcium and phosphorus, lactose, and salt-to-moisture ratio on Cheddar cheese quality: pH buffering properties of cheese.
Upreti P; Bühlmann P; Metzger LE
J Dairy Sci; 2006 Mar; 89(3):938-50. PubMed ID: 16507688
[TBL] [Abstract][Full Text] [Related]
16. Investigation of salt properties with electro-acoustic measurements and their effect on dynamic binding capacity in hydrophobic interaction chromatography.
Müller E; Faude A
J Chromatogr A; 2008 Jan; 1177(2):215-25. PubMed ID: 18037423
[TBL] [Abstract][Full Text] [Related]
17. Avoiding antibody aggregation during processing: establishing hold times.
Joshi V; Shivach T; Kumar V; Yadav N; Rathore A
Biotechnol J; 2014 Sep; 9(9):1195-205. PubMed ID: 24753430
[TBL] [Abstract][Full Text] [Related]
18. Thermophysical properties of carboxylic and amino acid buffers at subzero temperatures: relevance to frozen state stabilization.
Sundaramurthi P; Suryanarayanan R
J Phys Chem B; 2011 Jun; 115(21):7154-64. PubMed ID: 21561117
[TBL] [Abstract][Full Text] [Related]
19. Theory and computer programs for calculating solution pH, buffer formula, and buffer capacity for multiple component system at a given ionic strength and temperature.
Okamoto H; Mori K; Ohtsuka K; Ohuchi H; Ishii H
Pharm Res; 1997 Mar; 14(3):299-302. PubMed ID: 9098870
[TBL] [Abstract][Full Text] [Related]
20. Validation of a pH gradient-based ion-exchange chromatography method for high-resolution monoclonal antibody charge variant separations.
Rea JC; Moreno GT; Lou Y; Farnan D
J Pharm Biomed Anal; 2011 Jan; 54(2):317-23. PubMed ID: 20884149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
